Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): Explanation, elaboration, and checklist
Salameh, Jean Paul; Bossuyt, Patrick M.; McGrath, Trevor A.; Thombs, Brett D.; Hyde, Christopher J.; MacAskill, Petra; Deeks, Jonathan J.; Leeflang, Mariska; Korevaar, Daniël A.; Whiting, Penny; Takwoingi, Yemisi; Reitsma, Johannes B.; Cohen, Jérémie F.; Frank, Robert A.; Hunt, Harriet A.; Hooft, Lotty; Rutjes, Anne W.S.; Willis, Brian H.; Gatsonis, Constantine; Levis, Brooke; Moher, David; McInnes, Matthew D.F.
(2020) The BMJ, volume 370, issue 12
(Article)
Abstract
Systematic reviews of diagnostic test accuracy (DTA) studies are fundamental to the decision making process in evidence based medicine. Although such studies are regarded as high level evidence, these reviews are not always reported completely and transparently. Suboptimal reporting of DTA systematic reviews compromises their validity and generalisability, and subsequently
... read more
their value to key stakeholders. An extension of the PRISMA (preferred reporting items for systematic review and meta-analysis) statement was recently developed to improve the reporting quality of DTA systematic reviews. The PRISMA-DTA statement has 27 items, of which eight are unmodified from the original PRISMA statement. This article provides an explanation for the 19 new and modified items, along with their meaning and rationale. Examples of complete reporting are used for each item to illustrate best practices.
show less
Download/Full Text
The full text of this publication is not available.
Keywords: Checklist, Diagnostic Tests, Routine/standards, Editorial Policies, Evidence-Based Medicine, Guidelines as Topic, Humans, Meta-Analysis as Topic, Periodicals as Topic, Research Report/standards, Systematic Reviews as Topic, General Medicine, Research Support, Non-U.S. Gov't, Journal Article
ISSN: 0959-8146
Publisher: BMJ Publishing Group
Note: Funding Information: 9Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, University Medical Centres, University of Amsterdam, Amsterdam, Netherlands 10Department of Respiratory Medicine, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, Netherlands 11Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK 12Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Cochrane Netherlands, Utrecht, Netherlands 13Department of Paediatrics and Inserm UMR 1153 (Centre of Research in Epidemiology and Statistics), Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris Descartes University, Paris, France 14Institute of Social and Preventive Medicine, Berner Institut für Hausarztmedizin, University of Bern, Bern, Switzerland 15University of Birmingham, Birmingham, UK 16Brown University, Providence, RI, USA 17Lady Davis Institute of the Jewish General Hospital and Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada 18Ottawa Hospital Research Institute Clinical Epidemiology Program (Centre for Journalology), Ottawa, ON, Canada 19Clinical Epidemiology Programme, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1E 4M9, Canada Contributors: All authors approve of the final submitted version. All authors meet ICMJE criteria for authorship. All authors met ICMJE requirements for authorship, and contributed to the conceptualisation, writing, editing, and approval process. MDFM is the guarantor. The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted. Funding: J-PS is supported by the Ontario Graduate Scholarship, and MDFM is supported by the University of Ottawa Department of Radiology Research Stipend Programme. MDFM is supported by the Canadian Institute for Health Research (grant No 375751), Canadian Agency for Drugs and Technologies in Health, and STAndards for Reporting of Diagnostic accuracy studies group (STARD). CJH is supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula. BDT is supported by the Fonds de recherche du Québec-Santé researcher salary award. JJD is a United Kingdom NIHR Senior Investigator Emeritus, and is supported by the NIHR Birmingham Biomedical Research Centre. YT is funded by a UK NIHR postdoctoral fellowship, and is supported by the NIHR Birmingham Biomedical Research Centre. BHW is supported by a Medical Research Council Clinician Scientist Fellowship (grant No MR/N007999/1). BL is supported by a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship doctoral award. None of the funding bodies listed had any role in the design of the document; management, preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The views expressed are those of the authors and not necessarily those of the UK NHS, NIHR, or the Department of Health and Social Care. Funding Information: disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from the Ontario Graduate Scholarship and the University of Ottawa Department of Radiology Research Stipend Programme, Canadian Institute for Health Research, Canadian Agency for Drugs and Technologies in Health, and STAndards for Reporting of Diagnostic accuracy studies group, National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula, Fonds de recherche du Québec-Santé, NIHR, and Medical Research Council for the submitted work; no other relationships or activities that could appear to have influenced the submitted work. Provenance and peer review: Not commissioned; externally peer reviewed. Publisher Copyright: © Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to.
(Peer reviewed)